Cocoa and Carob Supplementation, Alone or in Combination with Metformin, Protects against Hepatorenal Injury in Zucker Diabetic Fatty Rats
The liver and kidneys are crucial for glucose homeostasis and are seriously damaged in diabetes. Cocoa and carob possess antidiabetic activity, but their hepatorenal protective effects, especially when combined with antidiabetic drugs, are unknown. The aim of this study is to investigate the effects of a cocoa-carob-supplemented diet (CC), either alone or in combination with metformin, on liver and kidney damage in Zucker diabetic fatty (ZDF) rats, a type 2 diabetes model. Male ZDF animals received a control or CC-supplemented diet, with or without metformin, and Zucker lean rats were fed the control diet. The CC-supplemented diet improved glucose tolerance and insulin resistance and alleviated functional and structural alterations in the diabetic liver and renal cortex. The CC-supplemented diet also ameliorated oxidative stress, downregulated apoptosis, and improved insulin signalling and glucose homeostasis. The combination of CC and metformin boosted several benefits as certain parameters related to morphological and structural alterations, apoptosis, oxidative stress, glucose homeostasis, and insulin resistance, were improved in comparison to animals receiving the CC-supplemented diet or metformin alone; these include the following: apoptotic index, Bax, hepatic insulin receptor or glutathione content, among others. These results demonstrate that the CC-supplemented diet alleviates the hepatorenal damage in type 2 diabetic ZDF rats, highlighting its potential alone or as an adjuvant therapy.
Authors
- Sonia Ramos (ORCID: https://orcid.org/0000-0003-2649-2616)
- María Elvira López‐Oliva (ORCID: https://orcid.org/0000-0002-0615-9149)
- Jara Pérez‐Jiménez (ORCID: https://orcid.org/0000-0002-2811-4558)
- María Ángeles Martín (ORCID: https://orcid.org/0000-0001-8173-4521)
- Esther García-Díez (ORCID: https://orcid.org/0000-0001-6871-7153)
Institutions
- Universidad Complutense de Madrid (ES)
- Instituto de Salud Carlos III (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Instituto de Ciencia y Tecnología de Alimentos y Nutrición (ES)
Publication Details
- Journal
- Nutrients
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3390/nu16183087
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Comunidad de Madrid
- European Commission
- European Regional Development Fund
- Agencia Estatal de Investigación